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Abstract
Background: Dysphagia occurs in up to 50% of patients admitted to hospital with acute strokes
with up to 27% remaining by seven days. Up to 8% continue to have swallowing problems six
months after their stroke with 1.7% still requiring enteral feeding. Nasogastric tubes (NGT) are the
most commonly used method for providing enteral nutrition in early stroke, however they are
easily and frequently removed leading to inadequate nutrition, early PEG (Percutaneous Endoscopic
Gastrostomy) insertion or abandoning of feeding attempts. Looped nasogastric tube feeding may
improve the delivery of nutrition to such patients.
Methods: Three centre, two arm randomised controlled trial, with 50 participants in each arm
comparing loop (the intervention) versus conventional nasogastric tube feeding. The primary
outcome measure is proportion of intended feed delivered in the first 2 weeks. The study is
designed to show a mean increase of feed delivery of 16% in the intervention group as compared
with the control group, with 90% power at a 5% significance level. Secondary outcomes are
treatment failures, mean volume of feed received, adverse events, cost-effectiveness, number of
chest x-rays, number of nasogastric tubes and tolerability.
Trial Registration: ISRCTN Number: ISRCTN61174381
Background
Dysphagia occurs in up to 50% of patients admitted to
hospital with hemispheric stroke [1-4]; up to 27% remain
at risk of aspiration by seven days, and up to 8% have
swallowing problems six months after their stroke [5]
with 1.7% still requiring tube feeding [6]. Nutritional sup-
plementation can reduce mortality in older people at risk
of malnutrition, although this has not been shown specif-
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patients with stroke are unable to take their full dietary
requirements normally, the delivery of a liquid feed
through a fine bore nasogastric tube is commonly used.
The tube is usually secured with adhesive tape around the
tube and to the patients face, and is often hooked behind
the ear, where more adhesive tape may be used.
Unfortunately nasogastric tubes are frequently inadvert-
ently dislodged, due to confusion, restlessness, communi-
cation and attention disorders during handling or normal
movement. Partial dislodgement may leave the tube mis-
placed in the lungs, leading to a risk of aspiration. Dis-
lodgement means that the tube needs to be re-sited,
possibly causing distress and discomfort to the patient.
Re-siting takes up nursing staff time, and may require a
chest x-ray to confirm that the tip of the tube is in the
stomach (especially in light of recent guidance [8]), add-
ing further costs and inconvenience. With multiple re-sit-
ings, and the associated delays, the amount of food that is
delivered by conventional nasogastric tube may be signif-
icantly below the intended amount [9,10]. This gives rise
to a risk of malnutrition, which is associated with poor
outcomes [11-13]. In view of these difficulties, percutane-
ous endoscopic gastrostomies are considered but the
results from the FOOD trial suggest that early PEG feeding
may be injurious [14]. It would be helpful to find a simple
and feasible means of using nasogastric tube feeding in
acutely dysphagic stroke patients that reduces the likeli-
hood of inadvertent nasogastric tube dislodgment.
Looped nasogastric feeding is a novel technique, early
reports of which suggest that it allows more secure place-
ment of a NG tube, but which is completely and easily
reversible [15]. In this technique, the end result is that a
loop is secured around the nasal septum; this loop is used
to secure the nasogastric tube in place. This technique may
result in considerably less tube dislodgement and more
reliable feeding without compromising patient accepta-
bility.
Methods/Design
Study design and participants
Study design
Three centre, two arm randomised controlled trial
(Queens Medical Centre, Nottingham; Nottingham City
Hospital, Derbyshire Royal Infirmary).
Subject definition
Any adult (> 18 years of age) with an acute clinically diag-
nosed stroke as defined by WHO standards ('A focal or at
times global neurological impairment of sudden onset
and lasting more than 24 hours, (or leading to death) and
of presumed vascular origin') [16]; managed on the Stroke
Unit. A clinical decision to attempt nasogastric tube feed-
ing according to usual protocols has been made by the
attending clinical team.
Exclusion criteria
Those not consenting to either NGT placement or to entry
into the trial. Those for whom NG feeding is determined
not to be in their best interests. Pregnant women. Those
with contraindications to NG feeding (nasal trauma/
malignancies).
Interventions
The research fellow and specialist stroke nurses will be
trained in siting the looped nasogastric tube (LNGT) as
well as conventional nasogastric tubes and will in turn
train the ward based nurses in the same techniques.
Product details
The nasal loop is manufactured by Applied Medical Tech-
nology Inc (United States) and distributed in the UK by
Pro-Care Ltd (UK). The CE mark is 93/42/EEC and the
product has been through the FDA approval process in the
United States.
Intervention group
The intervention group will receive all usual care except
that the looped nasogastric feeding tube will be used for
feed delivery. Subjects will have the loop component of
the NGT sited as per manufacturer's instructions. The loop
will be sited by either the research fellow, stroke nurses or
ward staff who will have been fully trained in placing the
loop. A nasogastric tube (NGT) will be passed and once in
place fixed using the loop, thus creating the looped
nasogastric tube. Upon confirmation that the NGT is cor-
rectly located, feeding will be commenced on an incre-
mental fashion as per local protocols, which will vary
between the centres
Control group
Participants will have a conventional nasogastric tube
(CNGT) sited either by trained ward staff or by the study
nurse. Upon confirmation that the NGT is correctly
located, feeding will be commenced on an incremental
fashion as per local protocols.
Hypotheses
This trial will assess feed and fluid delivery by nasogastric
tube; it does not seek primarily to assess nutritional out-
comes, functional improvement or mortality. There are
no well validated techniques for measuring change in
nutritional outcomes, especially in the context of stroke.
Anthropometric measures are difficult to obtain, because
of immobility and inability to stand and so measure
height. Biochemical indices (albumin, haemoglobin) are
liable to confounding because of intercurrent infection
and frequent comorbidity. Weight at baseline and twoPage 2 of 6
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allowing calculation of the Demiquet index [17] in order
to provide a measure of nutritional status. It is unlikely
that this trial will be able to show an improvement in
function or nutrition, as the power requirements would
require a number of participants an order of magnitude
greater than anticipated; similar arguments can be applied
to mortality.
The outcome measures are confined to the first two
weeks following the onset of stroke, as after two
weeks, there is the risk of contamination as individu-
als are offered PEG tubes as part of usual practice. For
the purposes of this trial, PEG use within two weeks is
considered as a failure of nasogastric feeding.
Primary hypothesis
Does use of the looped nasogastric tube in dysphagic
acute stroke patients result in a greater proportion of
nutritional prescription received per patient over a two
week period than conventional nasogastric tube use?
Secondary hypotheses
Does use of the looped nasogastric tube in dysphagic
acute stroke patients reduce the number of treatment fail-
ures during nasogastric feeding?
Does the use of the looped nasogastric tube enable greater
total delivery of artificial nutrition?
What is the frequency of adverse events using this tech-
nique?
Is the looped nasogastric tube cost-effective compared to
conventional nasogastric feeding, from an NHS perspec-
tive?
Does this technique reduce the proportion of patients
requiring early PEG insertions?
Does looped nasogastric feeding improve nutritional
indices compared to conventional nasogastric feeding?
Is loop feeding acceptable to patients?
Sample size
Pilot information shows that conventional nasogastric
feeding delivers approximately 43.5% of intended food (n
= 4) [18] though based on small numbers, this audit data
is consistent with previously published figures for NG
feed delivery [10]. We estimate that an improvement to
less than 60% would not be clinically worthwhile. No pre-
vious studies have been performed to assess the percent-
age of intended food that is delivered by a looped
nasogastric tube in a comparable population. Therefore,
we have assumed a conservative estimate for the common
standard deviation, which relates to an effect size of 0.660.
A sample size of 50 in each group will have 90% power to
be able to detect a 16.5% difference in the proportion of
intended feed delivered between the conventional and
looped nasogastric tube groups within two weeks assum-
ing that the common standard deviation is 25%1 using an
independent two sample t test with a 5% two-sided signif-
icance level. Allowing for dropouts (10%), we aim to
recruit a total sample size of 110 patients.
Randomisation and blinding
Participants will be randomised with equal probability to
usual care or the looped nasogastric technique by a com-
puter generated pseudo-random list using random per-
muted blocks of randomly varying size, created by the
Nottingham Clinical Trials Support Unit (CTSU) in
accordance with their standard operating procedures and
held on a secure server. The randomisation will be strati-
fied by centre and Oxford stroke classification (TACS ver-
sus non-TACS). TACS describes the most severe form of
stroke, with 90% of survivors either dead or heavily
dependent at one year. The outcome for individuals with
a non-TACS stroke is more favourable.
Access to the sequence will be confined to the CTSU Data
Manager. Investigators will access the treatment allocation
for each subject by means of a remote, internet-based ran-
domisation system developed and maintained by the
Nottingham CTSU. The sequence of treatment allocations
will be concealed until interventions have all been
assigned and recruitment, data collection, and statistical
analyses are complete.
It will not be possible to blind participants nor the data
collectors to the treatment allocation, due to the nature of
the intervention. However, all outcomes will be assessed
by a blinded assessor and analysis will be blind to the
treatment allocation.
Procedures and observations
Consent
Verbal and/or written consent will be obtained from all
participants where possible. Where dysphasia or other
barriers exist to obtaining verbal consent, if the clinicians
affirm that it is in the patient's best interest to participate
(at risk of minimal harm from the intervention), assent
will be sought from the next of kin, mirroring clinical
practice where consent to nasogastric feeding is estab-
lished. Information sheets will be provided to participants
and family members. Individuals who are entered into the
trial through a process of assent, will be reviewed regularly
and given the opportunity for fully informed consent.
They may choose to withdraw from the study at any stagePage 3 of 6
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based on Department of Health and MRC Guidance [19].
Patients not recruited into the study
Patients not recruited into the study will receive all usual
care, but will not be eligible for the looped nasogastric
tube, which is not standard therapy.
Baseline measurements
Age, sex, hospital, previous stroke, residential status,
Oxford stroke classification, NIHSS (National Institute of
Health Stroke Scale), time from stroke onset, Glasgow
Coma Scale score at 24 hours, weight and demi-span, and
whether treated for chest infection between admission
and allocation.
Outcome measurements
Definition of primary outcome
Primary outcome: percentage of nutritional prescription
received (amount delivered/amount intended as per dieti-
cian's prescription, including all feed and fluids) delivered
in the two weeks from allocation or at the point NG feed-
ing is stopped earlier on clinical grounds.
Secondary outcomes
• Number of times tube re-sited in two weeks; treatment
failure/completed treatment as specified (where treatment
failure means any occasion where attempts at nasogastric
tube feeding is ceased before normal oral intake is estab-
lished, and includes multiple failed attempts at passing a
tube, use of a PEG (in first two weeks), death or deteriora-
tion such that feeding is considered unsafe or unwanted)
• Mean volume of nasogastric feed delivered in the two
weeks from allocation
• Proportion of patients requiring early PEG insertions
• The technical efficiency (that is whether the best out-
come is being achieved within a given set of resources) of
looped nasogastric feeding after stroke compared to ordi-
nary nasogastric tubes will be assessed from an NHS per-
spective to see if this new technology offers value for
money. An intervention specific outcome will be used to
estimate an incremental cost-effectiveness ratio in the
form of a cost per change in percentage nutritional pre-
scription received.
• Change in Demiquet index from baseline to two weeks
(weight in kilograms)
• Tolerability/acceptability of technique by question-
naires to patients, families and nursing staff.
Adverse events
Tube related: reports of nasal irritation, complications
associated with nasogastric tube use
Aspiration pneumonia
Diarrhoea
Gastrointestinal bleeding
Refeeding syndrome
Follow up measures
We will follow up trial participants at three months; we
will only perform descriptive statistics due to lack of
power for formal statistical comparisons. These follow up
measures will include functional outcomes, length of stay,
feeding status, mortality and discharge placement. Tolera-
bility at three months will be assessed using a postal ques-
tionnaire and supplemented by interview when necessary.
This is important as perceptions of tube tolerability may
be different in the recovery phase.
Ascertainment of outcomes
Research Fellow and stroke nurses at each site will assist in
the collection of data, as well as training ward staff in the
technique of tube placement (including the looped tube).
Primary outcome
The volume of feed and fluid administered via the NGT
will be recorded by ward nursing staff on a daily basis. The
amount of feed delivered can be accurately recorded as
feed delivery is regulated using digital pumps. The pumps
enable accurate recording of the amount of feed delivered
(or not delivered) in millilitres. This information will be
collated by the Research Fellow when they visit the stroke
unit each day.
Secondary outcomes
Tube usage and tube related complications will be moni-
tored and the data collated using, to be completed for
each patient every 24 hours. The form will be completed
by ward staff with the support of the research fellow.
Treatment failure/completed treatment (where treatment
failure means any occasion where attempts at nasogastric
tube feeding is ceased before normal oral intake is estab-
lished, and includes multiple failed attempts at passing a
tube, use of a PEG (in the first two weeks), death or dete-
rioration such that feeding is considered unsafe or
unwanted) will also be recorded on this form. In such
cases, the circumstances will be abstracted from the med-
ical notes (< 1/2 side A4), without reference to treatment
group. The abstract will then be anonymised and e-mailed
to a medically qualified blinded assessor (RH). The asses-Page 4 of 6
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when feeding stopped because of return of oral feeding).
Weight (kilograms) and demispan (in cm: using stainless
steel tape measure, finger roots to sternal notch), will be
measured at baseline and at two weeks.
Both groups will be asked to complete a tolerability ques-
tionnaire regarding NG feeding, this will be adapted for
dysphasic patients.
Adverse events
Tube related adverse events will be monitored on a daily
basis, by ward nursing staff and the clinical fellow. Any
reports of nasal irritation, bleeding or discomfort will be
recorded.
Diarrhoea will be recorded using standard ward docu-
mentation (stool charts)
For the purposes of the study, aspiration pneumonia is
defined as the clinical diagnosis appearing in the medical
notes associated with a prescription of appropriate antibi-
otics. As with treatment failure/treatment complete, case
note abstraction will be used and the abstract sent to a
blinded assessor (JG). These data will be recorded by the
research fellow.
Follow up measures
At three months, the research fellow will check the medi-
cal records and/or with the patient's GP to check the
patient's status and will then confirm the discharge data,
feeding status and collect the Barthel Activities of Daily
Living score and Euro-QoL using a postal questionnaire.
Non-responders will be prompted via telephone 2 weeks
after the questionnaire has been sent and a home visit
arranged if necessary. Length of hospital stay (days), mor-
tality, residential status at discharge (own home/own
home with help/residential home/nursing home) will be
recorded by the research fellow based on a review of med-
ical records. Participants will also be asked to complete a
questionnaire about the tolerability of the feeding
method they received.
Cost-effectiveness
Cost-effectiveness analysis will be performed from an
NHS perspective only since in the trial period of two
weeks it is unlikely to have any cost impacts on the patient
or other services, such as social services. Components to
be considered in the cost-effectiveness analyses will
include:
• Cost of feed
• Feed wastage (number of bags of feed discarded due to
incomplete delivery of feed; cost per bag is likely to vary
between centres)
• Cost of nasogastric tube (NGT)
• Cost of looped NGT equipment
• Standardised costs based on sampling for: portering
time (to and from x-ray), nursing time (siting/re-siting
tubes), cost of PEG (equipment, placement, mainte-
nance), cost of complications (aspiration pneumonia)
and length of stay. We will also test for any differences in
discharge destination, but the study is not powered to
look at this specifically and it is not expected that any dif-
ferences will be observed
• Cost of treating any incident refeeding syndrome (phos-
phate, potassium an magnesium supplements as well as
treatment of the complications of refeeding syndrome,
such as fluid retention and neuromuscular fatigue)
• Cost of training in siting looped NGTs will be derived
from the pre-study preparation with the study nurses
• Resource use data will be derived from observation of a
sample in order to estimate standard unit costs. For exam-
ple, the cost of re-siting an NGT will be derived from
observing the process and attaching relevant unit costs –
products, time (nursing, medical, portering, and radiogra-
phy) and the cost of X-rays. Standard costs will then be
approximated. Other resource used will be collected from
clinical notes and costed using published unit cost data
[20,21]. The cost analysis results will be combined with
data on mean volume of nasogastric feed in order to pro-
duce an incremental cost-effectiveness ratio of the cost per
% change in mean volume of nasogastric feed.
Discussion
This study began recruitment in September 2006 and will
complete data collection by December 2007. The results
of the study will allow physicians caring for stroke
patients to make informed decisions about the best way to
provide nutrition to patients with dysphagia in the early
stages. The results may be applicable to other patients
with dysphagia or requiring nutritional support.
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